BioAdaptives

BioAdaptives Enterprise Value

The Enterprise Value (EV) of BioAdaptives (BDPT) as of Oct 25, 2026 is 370,086.53 USD. In the previous year, Enterprise Value (EV) was 349,729.53 USD — a change of 5.82% (higher).

Enterprise Value

370,086.53USD

YoY

5.82%

Last updated:

Enterprise Value (EV) of BioAdaptives is 2025 370,086.53 USD. Enterprise Value (EV) of BioAdaptives was 2024 349,729.53 USD. It decreases by 5.82% higher compared to the previous year.

The BioAdaptives Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
171,712.53 USD
Jan 1, 2019
501,129.53 USD
Jan 1, 2020
622,023.53 USD
Jan 1, 2021
497,809.53 USD
Jan 1, 2022
510,695.53 USD
Jan 1, 2023
412,505.53 USD
Jan 1, 2024
349,729.53 USD
Jan 1, 2025
370,086.53 USD
The BioAdaptives Enterprise Value history
YEAREnterprise ValueYoY
370,086.53USD+5.82%
349,729.53USD-15.22%
412,505.53USD-19.23%
510,695.53USD+2.59%
497,809.53USD-19.97%
622,023.53USD+24.12%
501,129.53USD+191.84%
171,712.53USD+22.18%
140,540.53USD+5.81%
132,820.53USD-4.54%
139,140.53USD+28.36%
108,397.53USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioAdaptives Stock analysis

What does BioAdaptives do? BioAdaptives, Inc. generates revenue through the sale of health and wellness products including dietary supplements, specialty food items, and devices that optimize bioelectromagnetic availability. The company markets PrimiCell and PrimiLive under a product agreement with Ferris Holding, Inc., targeting consumers seeking cognitive enhancement, fatigue reduction, and anti-aging solutions. PrimiTrim serves the weight control segment, while Equine Regen and Equine Regen Plus are in advanced testing for veterinary use. The firm also develops a dog product, expanding its wellness offerings across human and animal health markets. Ferris Holding, Inc. provides the intellectual property and products that BioAdaptives markets, including PrimiCell and PrimiLive, which are positioned for cognition, focus, and emotional wellness. The company's advanced-stage products Equine Regen and Equine Regen Plus cater to the veterinary segment, with PrimiTrim addressing weight management needs. BioAdaptives' product portfolio spans nutraceuticals, devices, and specialty foods designed to improve physical and emotional wellness across multiple consumer segments. BioAdaptives focuses on selling devices and nutraceuticals that target cognitive performance, fatigue reduction, and anti-aging, with PrimiCell and PrimiLive as key products under the Ferris agreement. The company's weight control solution PrimiTrim appeals to consumers seeking wellness through diet, while Equine Regen and Equine Regen Plus target animal health providers. The firm's development of a dog product further diversifies its offerings in the wellness market. BioAdaptives is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioAdaptives stock

Enterprise Value (EV) of BioAdaptives is 370,086.53 USD in 2025.

Enterprise Value (EV) of BioAdaptives changed from 349,729.53 USD to 370,086.53 USD, representing a 5.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) BioAdaptives since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s BioAdaptives with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — BioAdaptives

All Key Metrics — BioAdaptives